25
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Preoperative Prediction of Metastatic Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in cN0 Papillary Thyroid Carcinoma

ORCID Icon, , , ORCID Icon, ORCID Icon, , & show all
Pages 421-429 | Received 14 Jan 2024, Accepted 24 Apr 2024, Published online: 05 May 2024

References

  • Mulita F, Anjum F. Thyroid Adenoma. Treasure Island (FL): StatPearls Publishing; 2020.
  • Parad M, Fararouei M, Mirahmadizadeh A, Afrashteh S. Thyroid cancer and its associated factors: a population-based case-control study. Int J Cancer. 2021;149(3):514–521. doi:10.1002/ijc.33537
  • Qi G, Feng J, Wu W, et al. Prediction model of lymph node metastasis posterior to the right recurrent laryngeal nerve. Europ Archiv Oto-Rhino-Laryngol. 2023;280(7):3429–3435. doi:10.1007/s00405-023-07946-6
  • Zou M, Wang Y, Dong Y, Lai X, Li J. Clinical and sonographic features for the preoperative prediction of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma. J Endocrinol Invest. 2020;43(10):1511–1517. doi:10.1007/s40618-020-01238-0
  • Gong Y, Zuo Z, Tang K, et al. Multimodal predictive factors of metastasis in lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. Front Endocrinol. 2023;14:1187825. doi:10.3389/fendo.2023.1187825
  • Zhou M, Duan Y, Ye B, et al. Pattern and predictive factors of metastasis in lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. Front Endocrinol. 2022;13:914946. doi:10.3389/fendo.2022.914946
  • Lallemant B, Reynaud C, Alovisetti C, et al. Updated definition of level VI lymph node classification in the neck. Acta oto-laryngologica. 2007;127(3):318–322. doi:10.1080/00016480600806299
  • Chen B, Zhang Z, Wang K, et al. A multivariable model of BRAF and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manage Res. 2019;11:7211–7217. doi:10.2147/cmar.s199921
  • Du W, Fang Q, Zhang X, Dai L. Metastasis of cN0 papillary thyroid carcinoma of the isthmus to the lymph node posterior to the right recurrent laryngeal nerve. Front Endocrinol. 2021;12:677986. doi:10.3389/fendo.2021.677986
  • Ito Y, Fukushima M, Higashiyama T, et al. Incidence and predictors of right paraesophageal lymph node metastasis of N0 papillary thyroid carcinoma located in the right lobe. Endocr J. 2013;60(3):389–392. doi:10.1507/endocrj.ej12-0362
  • Li J, He G, Tong Y, et al. A novel scoring system for the risk of papillary thyroid cancer metastases in lymph nodes posterior to the right of the recurrent laryngeal nerve. Endocr Pract. 2021;27(1):15–20. doi:10.4158/ep-2020-0129
  • Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest. 2010;33(5):287–291. doi:10.1007/bf03346587
  • Kwak J, Han K, Yoon J, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892–899. doi:10.1148/radiol.11110206
  • Lu K, Zhang Y, Da J, et al. A novel scoring system for predicting the metastases of posterior right recurrent laryngeal nerve lymph node involvement in patients with papillary thyroid carcinoma by preoperative ultrasound. Front Endocrinol. 2021;12:738138. doi:10.3389/fendo.2021.738138
  • Zhang Z, Zhang X, Yin Y, et al. Integrating BRAF mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma. BMC Cancer. 2022;22(1):461. doi:10.1186/s12885-022-09550-z
  • Chen B, Zhang Z, Wang K, et al. Association of BRAFV600E mutation with ultrasonographic features and clinicopathologic characteristics of papillary thyroid microcarcinoma: a retrospective study of 116 cases. Clin Hemorheol Microcirc. 2019;73(4):545–552. doi:10.3233/ch-190568
  • Gao M, Ge M, Ji Q, et al. 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med. 2017;14(3):203–211. doi:10.20892/j.issn.2095-3941.2017.0051
  • Haugen B, Alexander E, Bible K, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020
  • Mulita F, Plachouri M, Liolis E, Vailas M, Panagopoulos K, Maroulis I. Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS). Endokrynologia Polska. 2021;72(2):143–144. doi:10.5603/EP.a2021.0018
  • Mulita F, Iliopoulos F, Tsilivigkos C, et al. Cancer rate of Bethesda category II thyroid nodules. Medicinski glasnik. 2022;19(1). doi:10.17392/1413-21
  • Zhang Z, Zhao S, Wang K, et al. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: evidence from an integrated bioinformatic analysis. Clin Hemorheol Microcirc. 2021;78(2):117–126. doi:10.3233/ch-201074
  • Chen B, Xu H, Zhang Y, et al. The diagnostic performances of conventional strain elastography (SE), acoustic radiation force impulse (ARFI) imaging and point shear-wave speed (pSWS) measurement for non-calcified thyroid nodules. Clin Hemorheol Microcirc. 2017;65(3):259–273. doi:10.3233/ch-16178
  • Brown R, de Souza J, Cohen E. Thyroid cancer: burden of illness and management of disease. J Cancer. 2011;2:193–199. doi:10.7150/jca.2.193
  • Mulita F, Verras G, Dafnomili V, et al. Thyroidectomy for the management of differentiated thyroid carcinoma and their outcome on early postoperative complications: a 6-year single-centre retrospective study. Chirurgia. 2022;117(5):556–562. doi:10.21614/chirurgia.2736
  • Mulita F, Theofanis G, Verras G, et al. Comparison of postoperative bleeding using harmonic scalpel and LigaSure in thyroid surgery: a 15-year single-centre retrospective study. Medicinski glasnik. 2023;20(2). doi:10.17392/1629-23
  • Xiao X, Wu Y, Zou L, Chen Y, Zhang C. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN papillary thyroid carcinoma. Gland Surg. 2022;11(7):1204–1211. doi:10.21037/gs-22-337
  • Lamartina L, Grani G, Arvat E, et al. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocrine Related Cancer. 2018;25(3):L7–L11. doi:10.1530/erc-17-0453
  • Yin L, Zhang W, Bai W, He W. Relationship between morphologic characteristics of ultrasonic calcification in thyroid nodules and thyroid carcinoma. Ultrasound Med Biol. 2019;46:1.
  • Li C, Zhou L, Dionigi G, Li F, Zhao Y, Sun H. The association between tumor tissue calcification, obesity, and thyroid cancer invasiveness in a cohort study - scienceDirect. Endocr Pract. 2020;26(8):830–839.
  • Zhou T, Wu F, Zhao L, Jiang K, Luo D. A meta-analysis of risk factors for lymph node posterior to the right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma. Gland Surg. 2021;2:6.
  • Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis. Int J Surg. 2018;3:50.
  • Kim S, Park I, Woo J, et al. Predicting factors for bilaterality in papillary thyroid carcinoma with tumor size <4 cm. Thyroid. 2017;27(2):207–214. doi:10.1089/thy.2016.0190
  • Park A, Son E, Kim J, et al. Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma. PLoS One. 2014;9(10):e110868. doi:10.1371/journal.pone.0110868
  • Pinyi Z, Bin Z, Jianlong B, Yao L, Weifeng Z. Risk factors and clinical indication of metastasis to lymph nodes posterior to right recurrent laryngeal nerve in papillary thyroid carcinoma: a single-center study in China. Head Neck. 2014;36(9):1335–1342. doi:10.1002/hed.23451
  • Yu Q, Ma D, Liu K, et al. Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma. J Endocrinol Invest. 2018;41(11):1333–1338. doi:10.1007/s40618-018-0874-4
  • Lee B, Lee J, Wang S, Kim Y, Kim I, Son S. Metastasis of right upper para-esophageal lymph nodes in central compartment lymph node dissection of papillary thyroid cancer. World J Surg. 2009;33(10):2094–2098. doi:10.1007/s00268-009-0149-5